The expression of common fragile sites and genetic predisposition to squamous cell lung cancers

Cancer Genetics and Cytogenetics

Volumn 95, Issue 2, 1997, Pages 153-158

  Egeli, Ünal ^a   Karadaǧ, Mehmet ^a   Tunca, Berrin ^a   Özyardímcí, Nihat ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 3P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC PREDISPOSITION; HUMAN; HUMAN GENETICS; LUNG CARCINOMA; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEDIGREE;

EID: 0031010323     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00215-4     Document Type: Article

References (26)

1. Yunis JJ, Soreng AL (1984): Constitutive fragile sites and cancer. Science 226:1199-1204.
2. Hecht F, Glover TW (1984): Cancer chromosome breakpoints and common fragile sites induced by aphidicolin. Cancer Genet Cytogenet 13:185-188.
3. Hecht F, Sandberg AA (1988): Introduction of fragile sites and cancer chromosome breakpoints. Cancer Genet Cytogenet 31:1-3.
4. Le Beau MM (1986): Chromosomal fragile sites and cancer specific rearrangements. Blood 67:849-858.
5. Le Beau MM (1988): Chromosomal fragile sites and cancer-specific breakpoints-A moderating viewpoint. Cancer Genet Cytogenet 31:55-61.
6. Liu G, Wang G, Li P (1989): The expression frequency of common fragile site and genetic susceptibility to lung cancers. Cancer Genet Cytogenet 42:107-114.
7. Sutherland GR, Jacky PB, Baker EG [1984]: Heritable fragile sites on human chromosomes XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17pl2. Am J Hum Genet 36:110-122.
8. Law MR (1990): Genetic predisposition to lung cancer. Br J Cancer 61:195-206.
9. Peto J (1980): Genetic predisposition to lung cancer. Banbury Report 4:203.
10. Ooi WL, Elstron RC, Chen VW, et al. (1986): Increased familial risk for lung cancer. J Cancer Inst 76:217.
11. Lynch HT (1976): Introduction to cancer genetics. In: Lynch HT, Charles CT, eds. Cancer Genetics. Springfield 3-34.
12. Benn PA, Perle MA (1986): Chromosomal staining and banding techniques. In: Human Cytogenetics: A Practical Approach. Rooney DE, Czepulkowski BH, eds. Oxford: IRL Pres Ltd. p. 64.
13. Sutherland GR, Mattei JF (1987): Report of the committee on the cytogenetic markers (HGM9). Cytogenet Cell Genet 46:316-324.
14. Ardisia C, Venti G, Antonietta M, et al. (1993): Expression of Aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. Cancer Genet Cytogenet 67:113-116.
15. Vernole P, Tedeschi B, Caporossi D, Nicoletti B (1988): A study on lymphocytes of neuroblastoma patients. Cancer Genet Cytogenet 36:13-23.
16. Porfirio B, Paladini P, Maccherini M, Gotti G, Cintorino M, De Marchi M (1989): Patients with different lung cancer show expression of fra(3)(p14) in aphidicolin-treated lymphocyte culture. Cancer Genet Cytogenet 43:95-101.
17. Dave BJ, Hsu TC, Hong WK, Pathak S (1994): Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol 5:733-740.
18. Vernole P, Tedeschi B, Nicoletti B (1990): Fragile sites induction by aphidicolin may be increased in parents of neuroblastoma patients. Cancer Genet Cytogent 50:35-44.
19. Kok K, Osinga J, Daris BM, et al. (1987): Deletion of DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330:578-581.
20. Hopkin JM, Evans JH (1980): Cigarette smoke-induced DNA damage and lung cancer risk. Nature 283:388-390.
21. Dusaka H, Abe S, Sasaki M, Miyamoto H, Kawakami Y (1987): Sister chromatid exchange induction by benzo(a)pyrene in cultured peripheral blood lymphocytes of lung cancer patients and healthy individuals with or without familial history of neoplasms. Int J Cancer 39:329-332.
22. Stimson P, Schants MD, Hsu TC (1989): Mutagen-induced chromosome fragility with in peripheral blood lymphocytes of head and neck cancer patients. Head and Neck 11:337-342.
23. Jorde LB, Carey JC, White RL (1995): Is genetic inheritance important in common cancers? In: Medical Genetics, ED Underown, ed Mosby-Year Book, Inc Missouri, p. 183.
24. Wolf CR (1986): Cytochrome P450s:-Polymorphic multigene families involved in carcinogen activation. Trends Genet:209.
25. Ocraft KP, Muskett JM, Brown S (1985): Localisation of the aryl hydrocarbon hydroxylase gene to the 2q31-2pter of chromosome 2. Ann Hum Genet 49:237.
26. Wiebel FJ, Hlavica P, Grzeschik KH (1981): Expression of aromatic polcylic hydrocarbon-induced mono-oxygenase (aryl hydrocarbon hydroxylase) in man x mouse hybrids is associated with human chromosome 2. Hum Genet 59:277.